These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2253217

  • 1. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM, Lemmon MJ.
    Cancer Res; 1990 Dec 15; 50(24):7745-9. PubMed ID: 2253217
    [Abstract] [Full Text] [Related]

  • 2. The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo.
    Langmuir VK, Mendonca HL.
    Radiat Res; 1992 Dec 15; 132(3):351-8. PubMed ID: 1475358
    [Abstract] [Full Text] [Related]

  • 3. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR, Brown JM.
    Radiat Res; 1993 Feb 15; 133(2):252-6. PubMed ID: 8438067
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.
    McKeown SR, Friery OP, McIntyre IA, Hejmadi MV, Patterson LH, Hirst DG.
    Br J Cancer Suppl; 1996 Jul 01; 27():S39-42. PubMed ID: 8763843
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A, Menke D, Dorie MJ, Brown JM.
    Radiat Oncol Investig; 1999 Jul 01; 7(3):163-9. PubMed ID: 10406058
    [Abstract] [Full Text] [Related]

  • 7. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
    Herman TS, Teicher BA, Coleman CN.
    Cancer Res; 1990 Aug 15; 50(16):5055-9. PubMed ID: 2379171
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
    Sun JR, Brown JM.
    Cancer Res; 1989 Oct 15; 49(20):5664-70. PubMed ID: 2790784
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Oct 15; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.
    Cancer J Sci Am; 1995 Oct 15; 1(1):43-8. PubMed ID: 9166453
    [Abstract] [Full Text] [Related]

  • 13. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1239-42. PubMed ID: 3744945
    [Abstract] [Full Text] [Related]

  • 14. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X, Tabassi K, Williams JA.
    Radiat Oncol Investig; 1999 Jul 15; 7(4):218-30. PubMed ID: 10492162
    [Abstract] [Full Text] [Related]

  • 15. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG, Menke DR, Dorie MJ, Brown JM.
    Cancer Res; 1997 Jul 15; 57(14):2922-8. PubMed ID: 9230202
    [Abstract] [Full Text] [Related]

  • 16. Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo.
    Teicher BA, Herman TS, Kaufmann ME.
    Radiat Res; 1989 Jul 15; 119(1):134-44. PubMed ID: 2756104
    [Abstract] [Full Text] [Related]

  • 17. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR, Siim BG, Denny WA, van Zijl PL, Taylor ML, Chambers DM, Roberts PB.
    Radiat Res; 1992 Sep 15; 131(3):257-65. PubMed ID: 1438685
    [Abstract] [Full Text] [Related]

  • 18. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
    Radiat Med; 1995 Sep 15; 13(6):291-5. PubMed ID: 8850370
    [Abstract] [Full Text] [Related]

  • 19. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1181-9. PubMed ID: 15234054
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
    Brown JM.
    Radiat Res; 1977 Dec 15; 72(3):469-86. PubMed ID: 594322
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.